New study links brain cell structures to memory loss in aging and dementia

FHS
August 12, 2024
11:44 am

Researchers assessed whether dendritic spine head diameter in the temporal cortex is a better predictor of episodic memory performance in older adults than synapse quantity, accounting for β amyloid plaques, neurofibrillary tangles, and sex.

Creating Access To Psychedelic Treatment | Interview with Therapsil’s Yasmeen deRosenroll

November 3, 2023

AI-Guidance Boosts Arrhythmia Ablation Success in Persistent Cases

BOSTON — For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after

May 19, 2024

BMS licenses TCR-T immunotherapy therapy from Immatics – Pharmaceutical Technology

Headquarters of Bristol-Myers Squibb (BMS) Germany in Munich, Germany. BMS has exercised opt-in rights for a new TCR-T therapy from Immatics. Credit: Shutterstock/nitpicker Bristol Myers

May 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.